Table 4.
Outcome measure | Pretreatment mean (SD) | Post-treatment mean (SD) | Difference, mean (95% CI) | p Value |
---|---|---|---|---|
Y-balance* | 240.5 (26.9) | 256.3 (20.8) | 15.8 (10.7 to 20.9) | <0.001 |
HROM (flexion)* | 110.2 (24.3) | 116.7 (23.3) | 6.5 (4.6 to 9.4) | <0.001 |
HROM (internal rot)* | 25.2 (13.7) | 29.8 (12.4) | 4.6 (2.7 to 6.6) | <0.001 |
Modified shuttle test | 10.3 (4.9) | 10.5 (5.1) | 0.2 (−1.2 to 0.7) | 0.60 |
Pain (VAS 1–100 mm) | 36.3 (24.2) | 34.8 (22.8) | 1.5 (−0.5 to 8.0) | 0.63 |
HAGOS subscales† | ||||
Pain | 37.7 (20.9) | 35.1 (23.7) | 2.6 (−1.5 to 6.8) | 0.21 |
Symptoms | 45.8 (23.2) | 46.3 (24.2) | 0.5 (−4.9 to 4.1) | 0.83 |
ADL | 32.2 (24.1) | 31.0 (24.7) | 1.2 (−2.1 to 4.7) | 0.46 |
Sport/recreation | 51.0 (28.1) | 48.5 (28.6) | 2.5 (−2.1 to 7.1) | 0.28 |
PA | 84.7 (24.9) | 77.5 (31.2) | 7.2 (0.0 to 14.4) | 0.05 |
QOL | 69.5 (20.4) | 64.9 (23.3) | 4.6 (−0.5 to 9.7) | 0.08 |
*Reflects pre-to-post treatment differences for the symptomatic hip. Bilateral hip pain scores are summed and aggregated for analysis.
†A normalised score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.
ADL, activities of daily living; HAGOS, Copenhagen Hip and Groin Outcome Score; HROM, hip range of motion; PA, participation in physical activity; QOL, quality of life; VAS, visual analogue scale.